These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 31896490

  • 1. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
    Tabibkhooei A, Izadpanahi M, Arab A, Zare-Mirzaei A, Minaeian S, Rostami A, Mohsenian A.
    Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
    [Abstract] [Full Text] [Related]

  • 2. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G, Terrenato I, Spagnuolo M, Carosi M, Cognetti G, Cicchillitti L, Sperati F, Villani V, Carapella C, Piaggio G, Pelosi A, Rizzo MG.
    J Exp Clin Cancer Res; 2016 Jul 30; 35(1):124. PubMed ID: 27476114
    [Abstract] [Full Text] [Related]

  • 3. Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma.
    Wang Q, Li P, Li A, Jiang W, Wang H, Wang J, Xie K.
    J Exp Clin Cancer Res; 2012 Nov 22; 31(1):97. PubMed ID: 23174013
    [Abstract] [Full Text] [Related]

  • 4. Circulating microRNA-137 is a potential biomarker for human glioblastoma.
    Li HY, Li YM, Li Y, Shi XW, Chen H.
    Eur Rev Med Pharmacol Sci; 2016 Sep 22; 20(17):3599-604. PubMed ID: 27649660
    [Abstract] [Full Text] [Related]

  • 5. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
    Guan Y, Chen L, Bao Y, Qiu B, Pang C, Cui R, Wang Y.
    Int J Clin Exp Pathol; 2015 Sep 22; 8(6):6576-88. PubMed ID: 26261539
    [Abstract] [Full Text] [Related]

  • 6. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
    Conti A, Romeo SG, Cama A, La Torre D, Barresi V, Pezzino G, Tomasello C, Cardali S, Angileri FF, Polito F, Ferlazzo G, Di Giorgio R, Germanò A, Aguennouz M.
    Tumour Biol; 2016 Oct 22; 37(10):14035-14048. PubMed ID: 27495233
    [Abstract] [Full Text] [Related]

  • 7. Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Analyses.
    Wei X, Zhang QM, Liu C, Wu S, Nong WX, Ge YY, Lin LN, Li F, Xie XX, Luo B.
    Curr Med Sci; 2022 Jun 22; 42(3):584-596. PubMed ID: 35678909
    [Abstract] [Full Text] [Related]

  • 8. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    Wang ZQ, Zhang MY, Deng ML, Weng NQ, Wang HY, Wu SX.
    PLoS One; 2017 Jun 22; 12(9):e0184969. PubMed ID: 28931080
    [Abstract] [Full Text] [Related]

  • 9. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
    Takkar S, Sharma V, Ghosh S, Suri A, Sarkar C, Kulshreshtha R.
    Cell Oncol (Dordr); 2021 Apr 22; 44(2):433-451. PubMed ID: 33469841
    [Abstract] [Full Text] [Related]

  • 10. Analysis of EZH2: micro-RNA network in low and high grade astrocytic tumors.
    Sharma V, Purkait S, Takkar S, Malgulwar PB, Kumar A, Pathak P, Suri V, Sharma MC, Suri A, Kale SS, Kulshreshtha R, Sarkar C.
    Brain Tumor Pathol; 2016 Apr 22; 33(2):117-28. PubMed ID: 26746204
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X, Lan F, Hu M, Pan Q, Wang Q, Wang J.
    J Neurosurg; 2016 Jan 22; 124(1):122-8. PubMed ID: 26230475
    [Abstract] [Full Text] [Related]

  • 12. Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.
    Visani M, de Biase D, Marucci G, Cerasoli S, Nigrisoli E, Bacchi Reggiani ML, Albani F, Baruzzi A, Pession A, PERNO study group.
    Mol Oncol; 2014 Mar 22; 8(2):417-30. PubMed ID: 24412053
    [Abstract] [Full Text] [Related]

  • 13. microRNA-10 and -221 modulate differential expression of Hippo signaling pathway in human astroglial tumors.
    Aguennouz M, Polito F, Visalli M, Vita G, Raffa G, Oteri R, Ghazi B, Scalia G, Angileri FF, Barresi V, Caffo M, Cardali S, Conti A, Macaione V, Bartolotta M, Giorgio RD, Germanò A.
    Cancer Treat Res Commun; 2020 Mar 22; 24():100203. PubMed ID: 32777750
    [Abstract] [Full Text] [Related]

  • 14. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
    Zhang H, Wang J, Wang Z, Ruan C, Wang L, Guo H.
    Cancer Biomark; 2019 Mar 22; 24(1):43-49. PubMed ID: 30530966
    [Abstract] [Full Text] [Related]

  • 15. Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma.
    Chen J, Yang L, Wang X.
    Cancer Biomark; 2017 Dec 06; 20(4):521-526. PubMed ID: 28946553
    [Abstract] [Full Text] [Related]

  • 16. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
    Shi R, Wang PY, Li XY, Chen JX, Li Y, Zhang XZ, Zhang CG, Jiang T, Li WB, Ding W, Cheng SJ.
    Oncotarget; 2015 Sep 29; 6(29):26971-81. PubMed ID: 26284486
    [Abstract] [Full Text] [Related]

  • 17. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
    Guan Y, Chen L, Bao Y, Pang C, Cui R, Li G, Liu J, Wang Y.
    Int J Clin Exp Pathol; 2015 Sep 29; 8(1):727-34. PubMed ID: 25755767
    [Abstract] [Full Text] [Related]

  • 18. MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review.
    Ahir BK, Ozer H, Engelhard HH, Lakka SS.
    Crit Rev Oncol Hematol; 2017 Dec 29; 120():22-33. PubMed ID: 29198335
    [Abstract] [Full Text] [Related]

  • 19. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
    Lan F, Qing Q, Pan Q, Hu M, Yu H, Yue X.
    Cell Oncol (Dordr); 2018 Feb 29; 41(1):25-33. PubMed ID: 29076027
    [Abstract] [Full Text] [Related]

  • 20. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q, Guan Y, Li Z, Wang Y, Liu Y, Cui R, Wang Y.
    J Exp Clin Cancer Res; 2019 Aug 16; 38(1):358. PubMed ID: 31419987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.